UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049852
Receipt number R000056757
Scientific Title To evaluate the effects of intake of test food on fat metabolism at rest.
Date of disclosure of the study information 2022/12/21
Last modified on 2024/01/17 14:08:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of effects induced by ingesting test foods on fat metabolism at rest.

Acronym

To evaluate the effects of intake of test food on fat metabolism at rest.

Scientific Title

To evaluate the effects of intake of test food on fat metabolism at rest.

Scientific Title:Acronym

To evaluate the effects of intake of test food on fat metabolism at rest.

Region

Japan


Condition

Condition

Healthy male adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify some kind of effect of a single intake, and continuous intakes of the food ingredient on fat metabolism at rest for male subjects ranging in age from 20 to 49 years old.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Fat oxidation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

To begin with, subjects will take the food-1 for 8 days. After more than 5 days of washout period, subjects will take the food-2 for 8 days.

Interventions/Control_2

To begin with, subjects will take the food-2 for 8 days. After more than 5 days of washout period, subjects will take the food-1 for 8 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male

Key inclusion criteria

(1) Male subjects ranging in age from 20 to 49 at informed consent.
(2) Subjects ranging in BMI from 18.5 to less than 25.0 kg/m2.
(3) Subjects who can visit the designated facility on measurement days.
(4) Subjects who can make self-judgment and voluntarily gave written informed consent.

Key exclusion criteria

(1) Subjects who have a habit of exercises.
(2) Subjects who can not brethe naturally using an aeromonitor.
(3) with irregular life rhythm (e.g., irregular shift work).
(4) Subjects with excessive alcohol intake.
(5) Subjects having a habit of smoking.
(6) Subjects with dieting or planning to diet during this study.
(7) Subjects having serious allergic rhinitis.
(8) Subjects who have periodically used health-specific / functional / health foods including supplements, which might affect fat metabolism.
(9) Subjects who take affecting medicines (except nonaffecting painkiller/antiinflamentry/external/eyedrops) within a month before the consent.
(10) Subjects with a maximal blood pressure of less than 90 mmHg.
(11) Subjects who donated their blood components and/or whole blood (0.2 L) within the past 4 weeks.
(12) Subjects who donated their whole blood (0.4 L) within the past 12 weeks.
(13) Subjects being collected in total of their blood (1.2 L) within the past 12 months and in this research.
(14) Subjects being under other clinical tests, or partook in those within the past four weeks, or will join those after the consent.
(15) Subjects who meet any of the following:
(a) suffering from heart, liver, or kidney disease (including complications of other diseases)
(b) having a history of cardiovascular disease
(c) diabetes
(d) allergic to the test food and required one.
(16) Others who were judged as inappropriate for participation by the principal/sub investigator.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hisako
Middle name
Last name Minami

Organization

Suntory beverage & Food limited.

Division name

Development & Designed Department

Zip code

211-0067

Address

13-2 Imaikami-cho, Nakahara-ku, Kawasaki, Kanagawa, JAPAN

TEL

050-3182-6161

Email

Hisako_Nakamura@suntory.co.jp


Public contact

Name of contact person

1st name Mariko
Middle name
Last name Sato

Organization

Suntory beverage & Food limited.

Division name

Development & Designed Department

Zip code

211-0067

Address

13-2 Imaikami-cho, Nakahara-ku, Kawasaki, Kanagawa, JAPAN

TEL

050-3182-0954

Homepage URL


Email

Mariko_Sato@suntory.co.jp


Sponsor or person

Institute

CPCC Company Limited

Institute

Department

Personal name



Funding Source

Organization

Suntory beverage & Food limited.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan

Tel

03-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 12 Month 20 Day

Date of IRB

2022 Year 12 Month 16 Day

Anticipated trial start date

2023 Year 01 Month 05 Day

Last follow-up date

2023 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 21 Day

Last modified on

2024 Year 01 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056757


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name